ATOS8:30 AMAtossa Therapeutics Announces Publication of KARISMA Endoxifen Trial Demonstrating Significant Reduction in Mammographic Breast Density in Healthy Premenopausal WomenTrial Results • Phase 2atossatherapeutics.com